Boon For Lupin As FDA Upgrades Somerset Site Status
Stricken US Facility Handed Voluntary Action Indicated Status By FDA
Looking to provide evidence of its extended measures to improve quality, compliance and oversight, Lupin has received positive news from the FDA for its US-based manufacturing facility in Somerset, New Jersey.
